Literature DB >> 20730299

Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson's disease.

Arthur Kummer1, Francisco Cardoso, Antonio Lucio Teixeira.   

Abstract

UNLABELLED: Anxiety is common in Parkinson's disease (PD), but studies concerning specific anxiety disorders are scarce. Essential psychometric properties of anxiety rating scales are also lacking.
OBJECTIVE: To investigate general anxiety disorder (GAD) in PD and psychometric properties of the Hamilton Anxiety Rating Scale (Ham-A).
METHOD: Ninety-one PD patients underwent neurological and psychiatric examination, which included the MINI-Plus, the Ham-A and the Hamilton Depression Rating Scale (Ham-D).
RESULTS: GAD was present in 30.8% of PD patients. Patients with GAD had longer disease duration (p=0.044) and were in use of higher doses of levodopa (p=0.034). They also tended to have more motor fluctuations and dyskinesias. The group with GAD scored higher in Ham-A (p<0.001), in the somatic (p=0.004) and psychic (p<0.001) subscales of Ham-A, and in Ham-D (p=0.004). The Ham-A showed good internal consistency (Cronbach's alpha=0.893) and a cutoff score of 10/11 is suggested to screen for GAD.
CONCLUSION: GAD is frequent in PD and the Ham-A may be a useful instrument to screen for this disorder.

Entities:  

Mesh:

Year:  2010        PMID: 20730299     DOI: 10.1590/s0004-282x2010000400005

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  17 in total

1.  Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Authors:  Matthew Swan; Nancy Doan; Robert A Ortega; Matthew Barrett; William Nichols; Laurie Ozelius; Jeannie Soto-Valencia; Sarah Boschung; Andres Deik; Harini Sarva; Jose Cabassa; Brooke Johannes; Deborah Raymond; Karen Marder; Nir Giladi; Joan Miravite; William Severt; Rivka Sachdev; Vicki Shanker; Susan Bressman; Rachel Saunders-Pullman
Journal:  J Neurol Sci       Date:  2016-08-30       Impact factor: 3.181

2.  Cortical atrophy is associated with cognitive impairment in Parkinson's disease: a combined analysis of cortical thickness and functional connectivity.

Authors:  Yongyun Zhu; Baiyuan Yang; Chuanbin Zhou; Chao Gao; Yanfei Hu; Wei Fang Yin; Kangfu Yin; Yangfan Zhu; Guoliang Jiang; Hui Ren; Ailan Pang; Xinglong Yang
Journal:  Brain Imaging Behav       Date:  2022-08-31       Impact factor: 3.224

3.  Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease.

Authors:  Nadeeka N W Dissanayaka; Elizabeth White; John D O'Sullivan; Rodney Marsh; Peter A Silburn; David A Copland; George D Mellick; Gerard J Byrne
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

Review 4.  Understanding, Impact, and Communication of "Off" Periods in Parkinson's Disease: A Scoping Review.

Authors:  Tara Rastgardani; Melissa J Armstrong; Anna R Gagliardi; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2018-10-09

5.  Comparing the Effects of Melatonin and Zolpidem on Sleep Quality, Depression, and Anxiety in PatientsWithColorectalCancerUndergoingChemotherapy.

Authors:  Maryam Shahrokhi; Padideh Ghaeli; Pantea Arya; Alia Shakiba; Afsaneh Noormandi; Mehdi Soleimani; Mohsen Esfandbod
Journal:  Basic Clin Neurosci       Date:  2021-01-01

6.  Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population.

Authors:  Carlos Tovilla-Zárate; Isela Juárez-Rojop; Yesenia Peralta Jimenez; María Antonia Jiménez; Silvia Vázquez; Deysi Bermúdez-Ocaña; Teresa Ramón-Frías; Alma D Genis Mendoza; Sherezada Pool García; Lilia López Narváez
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

7.  Psychiatric disorders in primary focal dystonia and in Parkinson's disease.

Authors:  Fernando Mv Dias; Arthur Kummer; Flávia Cp Doyle; Estefânia Harsányi; Francisco Cardoso; Leonardo F Fontenelle; Antônio Lúcio Teixeira
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-14       Impact factor: 2.570

8.  Increased Central Nervous System Interleukin-8 in a Majority Postlaminectomy Syndrome Chronic Pain Population.

Authors:  Sarah E Giron; Martin F Bjurstrom; Charles A Griffis; F Michael Ferrante; Irene I Wu; Andrea L Nicol; Tristan R Grogan; Joseph F Burkard; Michael R Irwin; Elizabeth Crabb Breen
Journal:  Pain Med       Date:  2018-05-01       Impact factor: 3.637

9.  Anxiety, Gambling Activity, and Neurocognition: A Dimensional Approach to a Non-Treatment-Seeking Sample.

Authors:  Gustavo C Medeiros; Daniela G Sampaio; Eric W Leppink; Samuel R Chamberlain; Jon E Grant
Journal:  J Behav Addict       Date:  2016-06       Impact factor: 6.756

10.  A combined study of 18F-FDG PET-CT and fMRI for assessing resting cerebral function in patients with major depressive disorder.

Authors:  Chang Fu; Hongju Zhang; Ang Xuan; Yongju Gao; Junling Xu; Dapeng Shi
Journal:  Exp Ther Med       Date:  2018-07-09       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.